O'Sullivan C A, Henein M Y, Sutton R, Coats A J, Sutton G C, Gibson D G
Royal Brompton Hospital, London, UK.
Heart. 1998 May;79(5):468-73. doi: 10.1136/hrt.79.5.468.
To assess possible ECG changes caused by dobutamine stress and their relation to wall motion disturbances in patients with coronary artery disease.
Prospective recording and analysis of 12 lead ECG at rest and during each stage of dobutamine stress echocardiography, and correlation with wall motion changes.
A tertiary referral centre for cardiac disease equipped with non-invasive facilities for pharmacological stress tests.
27 patients, mean (SD) age 60 (8) years, with documented evidence of coronary artery disease in whom dobutamine stress echo was clinically indicated, and 17 controls of similar age.
In controls, all ECG intervals shortened with increasing heart rate but in the patient group only PR and QT intervals shortened while QRS duration broadened and QTc interval prolonged progressively. In the 27 patients, 16 developed chest pain, 15 with reduced left ventricular long axis systolic excursion (p < 0.001), and all showed reduced peak lengthening rate; ST segment shift appeared in 16, 13 of whom developed chest pain, but did not correlate with reduction of either systolic long axis excursion or peak lengthening rate; QRS duration broadened in 20, 16 with reduction of long axis excursion (p < 0.02) which was more often seen at the septum (p < 0.005); QTc interval prolonged in 19, all of whom had associated reduction of peak long axis lengthening rate (p < 0.02).
QRS duration and QTc interval both normally shorten with dobutamine stress, while in coronary artery disease they both lengthen: changes in QRS duration correlate with systolic and QTc interval with diastolic left ventricular wall motion disturbances. ST segment shift also occurred in most patients, but without consistent correlation with wall motion abnormalities. It was thus less discriminating than the other two abnormalities in this respect.
评估多巴酚丁胺负荷试验引起的可能的心电图变化及其与冠心病患者室壁运动障碍的关系。
对静息状态及多巴酚丁胺负荷超声心动图各阶段的12导联心电图进行前瞻性记录和分析,并与室壁运动变化进行相关性分析。
一家配备有药物负荷试验无创设备的三级心脏病转诊中心。
27例平均(标准差)年龄为60(8)岁、有冠状动脉疾病记录证据且临床表明需进行多巴酚丁胺负荷超声心动图检查的患者,以及17例年龄相仿的对照者。
在对照组中,所有心电图间期均随心率增加而缩短,但在患者组中,只有PR间期和QT间期缩短,而QRS时限增宽且QTc间期逐渐延长。在27例患者中,16例出现胸痛,15例左心室长轴收缩期偏移减小(p<0.001),且所有患者的峰值延长率均降低;16例出现ST段移位,其中13例出现胸痛,但与收缩期长轴偏移减小或峰值延长率均无相关性;20例QRS时限增宽,其中16例长轴偏移减小(p<0.02),在室间隔更常见(p<0.005);19例QTc间期延长,所有患者的峰值长轴延长率均降低(p<0.02)。
多巴酚丁胺负荷试验时,正常情况下QRS时限和QTc间期均缩短,而在冠心病患者中二者均延长:QRS时限的变化与收缩期相关,QTc间期的变化与舒张期左心室壁运动障碍相关。大多数患者也出现ST段移位,但与室壁运动异常无一致的相关性。因此,在这方面它的鉴别能力不如其他两种异常。